Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusong Lin

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 21, 2019
<sup>18</sup>F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse gliomaZiren Kong, Yusong Lin, Chendan Jiang, et al.
Frontiers in Oncology|December 6, 2019
A Non-invasive Radiomic Method Using <sup>18</sup>F-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With GliomaLongfei Li, Wei Mu, Yaning Wang, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 21, 2019
<sup>18</sup>F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse gliomaZiren Kong, Yusong Lin, Chendan Jiang, et al.
Frontiers in Oncology|December 6, 2019
A Non-invasive Radiomic Method Using <sup>18</sup>F-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With GliomaLongfei Li, Wei Mu, Yaning Wang, et al.
Pageof 5